Pictet & Cie Europe SA cut its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 37.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 958 shares of the medical instruments supplier’s stock after selling 564 shares during the period. Pictet & […]
abrdn plc boosted its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 8.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 352,988 shares of the medical instruments supplier’s stock after buying an additional 26,289 shares during the period. […]
Kinneret Advisory LLC reduced its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 5.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,042 shares of the medical instruments supplier’s stock after selling 271 shares during the quarter. Kinneret Advisory LLC’s holdings in Insulet […]
EULAV Asset Management reduced its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 14.8% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,522 shares of the medical instruments supplier’s stock after selling 1,478 shares during the quarter. EULAV […]
AIA Group Ltd boosted its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 103.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,648 shares of the medical instruments supplier’s stock after acquiring an additional 2,867 shares during […]